Alterity Therapeutics (PRNAD) Other Accumulated Expenses (2019 - 2025)

Alterity Therapeutics (PRNAD) has reported Other Accumulated Expenses for 7 consecutive years, with $89.29 the latest figure, recorded in Q4 2025.

• In Q4 2025, Other Accumulated Expenses fell 7.11% year-over-year to $89.29; the TTM figure through Dec 2025 stood at $89.29 (down 7.11% YoY), while the FY2025 annual figure was $89.02, down 99.86% from the prior year.
• Other Accumulated Expenses came in at $89.29 for Q4 2025 at Alterity Therapeutics, roughly flat from $89.02 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $116587.2 in Q4 2023, with the low at $89.02 in Q2 2025.
• Average Other Accumulated Expenses over 5 years is $41232.4, with a median of $25362.7 recorded in 2021.
• Across the five-year window, Other Accumulated Expenses surged 434.74% in 2021 and sank 99.92% in 2024, its largest moves.
• Year by year, Other Accumulated Expenses stood at $11049.2 in 2021, then soared by 259.09% to $39676.2 in 2022, then soared by 193.85% to $116587.2 in 2023, then tumbled by 99.92% to $96.13 in 2024, then fell by 7.11% to $89.29 in 2025.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $89.29, $89.02, and $96.13 for Q4 2025, Q2 2025, and Q4 2024 respectively.